首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Bysspectin A, an unusual octaketide dimer and the precursor derivatives from the endophytic fungus Byssochlamys spectabilis IMM0002 and their biological activities
【24h】

Bysspectin A, an unusual octaketide dimer and the precursor derivatives from the endophytic fungus Byssochlamys spectabilis IMM0002 and their biological activities

机译:拜访A,异常的八大烷基二聚体和来自内参真菌的前体衍生物ByssoChlamys Spectabilis IMM0002及其生物学活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Bysspectin A ( 1 ), a polyketide-derived octaketide dimer with a novel carbon skeleton, and two new precursor derivatives, bysspectins B and C ( 2 and 3 ), were obtained from an organic extract of the endophytic fungus Byssochlamys spectabilis that had been isolated from a leaf tissue of the traditional Chinese medicinal plant Edgeworthia chrysantha , together with a known octaketide, paecilocin A ( 4 ). Their structures were determined by HRMS, 1D and 2D NMR spectroscopic analysis. A plausible route for their biosynthetic pathway is proposed. Compounds 1 – 3 were tested for their antimicrobial activities. Only compound 3 was weakly active against Escherichia coli and Staphyloccocus aureus with MIC values of 32 and 64? μ g/mL, respectively. Further, the inhibitory effects on human carboxylesterases (hCE1, hCE2) of compounds 1 and 4 were evaluated. The results demonstrated that bysspectin A ( 1 ) was a novel and highly selective inhibitor against hCE2 with the IC 50 value of 2.01?μM. Docking simulation also demonstrated that active compound 1 created interaction with the Ser-288 (the catalytic amino-acid in the catalytic cavity) of hCE2 via hydrogen bonding, revealing its highly selective inhibition toward hCE2. Graphical abstract Display Omitted Highlights ? HPLC-PDA-MS HPLC-DAD-HRMS was applied to look for novel natural products with remarkable bioactivity. ? Isolation of a polyketide-derived octaketide dimer with a novel carbon skeleton. ? Bysspectin A ( 1 ) was a novel and highly selective inhibitor against hCE2. ? Bysspectin A ( 1 ) created interaction with the Ser-288 of hCE2 via hydrogen bonding.
机译:摘要除耻蛋白A(1),用新型碳骨架的聚酮衍生的八烷基二聚体和两种新的前体衍生物,BySSpectins B和C(2和3)获得,其是由曾经的内生真菌的有机提取物获得的与传统的中国药用植物EdgeWorthia Chrysantha的叶子组织分离,与已知的八烷基,睡衣A(4)。它们的结构由HRMS,1D和2D NMR光谱分析测定。提出了一种可粘合的生物合成途径。测试化合物1-3的抗微生物活性。只有32和64的MIC值才对大肠杆菌和金黄色葡萄球菌弱活跃的化合物3是弱活性的? μg/ ml分别。此外,评价对化合物1和4的人羧基酯酶(HCE1,HCE2)的抑制作用。结果表明,除黑色50值为2.01μm的IC 50值是一种新的和高度选择性抑制剂。对接模拟还证明了活性化合物1通过HCE2的Ser-288(催化腔中的催化氨酸中的催化氨基酸)的相互作用通过氢键形成,揭示其对HCE2的高度选择性抑制。图形抽象显示省略了亮点?施用HPLC-PDA-MS HPLC-DAD-HMRMS以寻找具有显着生物活性的新型天然产物。还是用新型碳骨架分离聚酮衍生的八烷基二聚体。还是拜访1(1)是对HCE2的新颖且高度选择性的抑制剂。还是除耻A(1)通过氢键与HCE2的SER-288产生相互作用。

著录项

  • 来源
  • 作者单位

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    School of Pharmaceutical Sciences Zhejiang University of Technology;

    Institute of Interdisciplinary Medicine Shanghai University of Traditional Chinese Medicine;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    Department of Chemistry and Life Science Qinghai University for Nationalities;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

    Institute of Interdisciplinary Medicine Shanghai University of Traditional Chinese Medicine;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Byssochlamys spectabilis; Polyketide-derived octaketide dimer; Human carboxylesterase 2; Selective inhibitor;

    机译:ByssoChlamys Spectabilis;聚酮衍生的八烷基二聚体;人羧酸酯酶2;选择性抑制剂;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号